<p>Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib</p>Hongge Liang, Mengzhao Wang, Junling Li et al.|Cancer Management and Research|2019Cited by 6
[Clinical-radiological-pathological Characteristics of 297 Cases of Surgical Pathology Confirmed Benign Pulmonary Lesions in Which Malignancy Could Not Be Excluded in Preoperative Assessment: A Retrospective Cohort Analysis in a Single Chinese Hospital].Yongjian Liu, Mengzhao Wang, Hongge Liang et al.|PubMed|2020Cited by 5